Page last updated: 2024-11-06

mitomycin and Chagas Disease

mitomycin has been researched along with Chagas Disease in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paucar, R1
Martín-Escolano, R1
Moreno-Viguri, E1
Azqueta, A1
Cirauqui, N1
Marín, C1
Sánchez-Moreno, M1
Pérez-Silanes, S1

Other Studies

1 other study available for mitomycin and Chagas Disease

ArticleYear
Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Bioorganic & medicinal chemistry, 2019, 09-01, Volume: 27, Issue:17

    Topics: Animals; Cells, Cultured; Chagas Disease; Chlorocebus aethiops; Cyclophosphamide; Dose-Response Rela

2019